CLAREMONT, CA– (April 18, 2017) – Kiwa Bio-Tech Products Group Corporation (OTCQB: KWBT). On April 18, 2016, Kiwa Bio-Tech Products Group Corporation (“Kiwa” or the “Company”)) reported its operating results for most recent fiscal year ended December 31, 2016. For the fourth quarter, Kiwa reported revenue of
$9,617,845 and net income of $963,296.
“2016 was a remarkable year for the Company. We made progress in all aspects of our corporate development, from corporate structuring to fundraising, from new product development to market expansion, and from revenue generation to cost saving,” stated Yvonne Wang, CEO of Kiwa. “The Company’s profit was recognized through its wholly-owned China subsidiary,” Wang commented.
Wang continued, “Looking forward to 2017, we see continued opportunities for growth. On one hand, we are very pleased that we exceeded our business plan in 2016, on the other, we are committed to working more diligently to improve our fundamentals and deliver excellent results to our investors in 2017.”
